0

“Beehind the Buzz” Show: Featuring Q BioMed Inc. (OTCQB: QBIO) CEO Denis Corin

Q BioMed Inc. (OTCQB: QBIO) aims to accelerate the monetization of biomedical technologies through rapid innovation and collaborative partnerships with industry-leading researchers. Q BioMed believes its assets in oncology, vascular disease, and rare orphan diseases address unmet medical needs and large markets. Mr. Denis D. Corin is Chief Executive Officer and Chairman of the Board. […]

0

“Behind the Buzz” Show: Featuring Spinalcyte, LLC CEO Pete O’Heeron

Based in Houston, Texas, SpinalCyte, LLC, is a regenerative medicine company developing an innovative solution for spinal replacement using human dermal fibroblasts. Currently, SpinalCyte holds 39 U.S. and international issued patents and has filed for an additional 100+ patents pending and issued across a variety of clinical pathways, including disc degeneration, cancer, diabetes, liver failure […]

0

“Behind the Buzz” Show: MustGrow Biologics (CSE: MGRO) President & CEO Corey Giasson

MustGrow Biologics Corp. (CSE: MGRO) is an agricultural biotech company focused on providing natural science-based biological solutions for cannabis and fruit & vegetable cultivation. In cannabis, the Company is currently developing reliable, safe and biological solutions that adhere to Health Canada’s strict regulations. The Company currently has three products suited for the cannabis market: a […]

0

“Buzz on the Street” Show: Featuring Biome Grow Inc. (OTCQB: BIOIF) (CSE: BIO) Coverage

0

“Buzz on the Street” Show: Featuring Pressure Biosciences (OTCQB: PBIO) Biotech Research

Pressure BioSciences, Inc. (OTCQB: PBIO) announced the establishment of a Center of Excellence at Dr. Christine Vogel’s laboratory at New York University’s Center for Genomics and Systems Biology. Pressure BioSciences, Inc. is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry. Our products are based […]

0

“Buzz on the Street” Show: Featuring Pressure Biosciences Inc. (OTCQB: PBIO) Coverage

Pressure BioSciences, Inc. (OTCQB: PBIO) on the 13th, released a short video demonstrating the Company’s proprietary Ultra Shear Technology (USTTM) platform and its ability to create extremely small, nanometer-scale oil droplets that effectively dissolve in water (nanoemulsions) to provide optimized bioavailability for absorption. Pressure BioSciences, Inc. announced that analytical testing on hemp-derived CBD oil processed […]

0

“Buzz on the Street” Show: Featuring Pressure Biosciences Inc. (OTCQB: PBIO) Medical News

Pressure BioSciences, Inc. (OTCQB: PBIO) a leader in the development and sale of pressure-based instruments and platform technologies to the life sciences and other industries worldwide, today announced a collaboration with The Steinbeis Centre for Biopolymer Analysis & Biomedical Mass Spectrometry, a world-renown German research organization. Pressure BioSciences, Inc. is pressure-based platform solutions for the […]

0

“Buzz on the Street” Show: Pressure Biosciences (OTCQB: PBIO) Cancer Biomarker Discovery

Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” and the “Company”) is a leader in the development and sale of innovative, broadly enabling, pressure-based instruments and related consumables for the worldwide life sciences and other industries. The Company announced today the publication of two scientific journal articles, led by independent teams of scientists in China and Australia, […]

0

“Buzz on the Street” Show: Pressure Biosciences (OTCQB: PBIO) Presents at Gynecologic Cancer Meeting

Pressure BioSciences, Inc. (OTCQB: PBIO) announced the Company’s patented pressure cycling technology (“PCT”) platform was featured as an integral part of a new, innovative workflow for the analysis of proteins from cancer biopsy samples. This workflow was presented in a plenary session at the Annual Meeting of the International Gynecologic Cancer Society (“IGCS”) on September […]

0

“Buzz on the Street” Show: Q BioMed (OTCQB: QBIO) Mannin Research Reports Data: Acute Kidney Injury

Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotech company, is announcing today that its technology research partner Mannin Research Inc. (Mannin) presented positive data on a potential new treatment for acute kidney injury (AKI). The data was presented at the American Society for Nephrology 2019 Annual Meeting held in Washington DC. Q BioMed Inc. […]